Michael Riggs
8Patents
4h-index
8Co-inventors
46Inventor score
Filing activity: Mar 27, 1997 → Feb 6, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8394379B2 | Targeted cryptosporidium biocides | Chemistry; Metallurgy | 10 | Active |
| US6110463A | Anti-Cryptosporidium parvum preparations | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6323020A | Neutralization-sensitive epitopes of Cryptosporidium parvum | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7566447B2 | Biocides | Human Necessities | 4 | Expired |
| US8703134B2 | Targeted cryptosporidium biocides | Emerging Cross-Sectional Technologies | 2 | Active |
| US6682737B1 | Anti-cryptosporidium parvum preparations | Emerging Cross-Sectional Technologies | 2 | Expired |
| US6730307B2 | Anti-cryptosporidium parvum preparations | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6759048B1 | Neutralization-sensitive epitopes of Cryptosporidium parvum | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.